Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the heart and lungs, according to researchers at The University of Texas MD Anderson Cancer Center.
Daiichi Sankyo and Depixus partner to accelerate RNA-targeted drug discovery
Share this article Depixus’ MAGNA technology can be used to study molecular interactions between DNA, RNA, proteins, and small molecule therapeutics, which can in turn
December 13, 2023